Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan N Chi

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Neuro-Oncology|March 19, 2019
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymomaMark W Kieran, Liliana Goumnerova, Peter Manley, et al.
Pediatric Blood & Cancer|May 26, 2017
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium studyMargaret E Macy, Mark W Kieran, Susan N Chi, et al.
Pediatric Blood & Cancer|May 12, 2018
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous systemPeter E Manley, Tanya Trippett, Amy A Smith, et al.
Cancer Medicine|March 22, 2021
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncologyDavid S Shulman, Lulla V Kiwinda, Stacey Edwards, et al.
Imaging Neuroscience (Cambridge, Mass.)|January 8, 2026
TissUnet: Improved extracranial tissue and cranium segmentation for children through adulthoodMarkiian Mandzak, Elvira Yang, Anna Zapaishchykova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumorSusan N Chi, Mary Ann Zimmerman, Xiaopan Yao, et al.
Neuro-Oncology|April 3, 2020
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium studyNicole J Ullrich, Sanjay P Prabhu, Alyssa T Reddy, et al.
Research Square|April 8, 2025
<i>SMARCB1</i> missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
JAMA Oncology|October 26, 2023
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled TrialAndreas Peyrl, Monika Chocholous, Magnus Sabel, et al.
Nature Communications|April 8, 2026
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Neuro-Oncology|March 19, 2019
Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymomaMark W Kieran, Liliana Goumnerova, Peter Manley, et al.
Pediatric Blood & Cancer|May 26, 2017
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium studyMargaret E Macy, Mark W Kieran, Susan N Chi, et al.
Pediatric Blood & Cancer|May 12, 2018
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous systemPeter E Manley, Tanya Trippett, Amy A Smith, et al.
Cancer Medicine|March 22, 2021
Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncologyDavid S Shulman, Lulla V Kiwinda, Stacey Edwards, et al.
Imaging Neuroscience (Cambridge, Mass.)|January 8, 2026
TissUnet: Improved extracranial tissue and cranium segmentation for children through adulthoodMarkiian Mandzak, Elvira Yang, Anna Zapaishchykova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumorSusan N Chi, Mary Ann Zimmerman, Xiaopan Yao, et al.
Neuro-Oncology|April 3, 2020
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium studyNicole J Ullrich, Sanjay P Prabhu, Alyssa T Reddy, et al.
Research Square|April 8, 2025
<i>SMARCB1</i> missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
JAMA Oncology|October 26, 2023
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled TrialAndreas Peyrl, Monika Chocholous, Magnus Sabel, et al.
Nature Communications|April 8, 2026
SMARCB1 missense mutants disrupt SWI/SNF complex stability and remodeling activityGarrett W Cooper, Benjamin P Lee, Won Jun Kim, et al.
Pageof 9